:
Cancer and tumor has been major reasons for numerous deaths in this century across the world. Many strategies
have been designed to treat, diagnose or prevent cancer. The success of the chemotherapy largely depends on the drug
targeting. The advent of nanotechnology has vastly improved the drug delivery for targeting and diagnosis. Nevertheless,
the accuracy of drug targeting with polymeric nanoparticles has always been questionable. The polymeric nanoparticles
synthesised from varieties of lipid based compounds or combined with vectors such as liposomes, ethosomes, and
transferosomes may allow the drug to overcome the issue of resistance to drug absorption in biological membranes. The
combined effects of lipid based nanocarriers is known to improve the efficacy and accuracy of polymeric nanoparticles. The
present review explores the application of lipid based nano carriers in treatment. A special focus is given to the use of lipid
based nanocarriers in the treatment, diagnosis and mitigation of cancer located in blood, brain, lung and colon. The treatment
of these cancers has always been questionable as the chances of relapse is very high. The review encompasses the use of
lipid based nanocarriers in targeting tissue specific cancer cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.